Oman vs Sierra Leone: HIV-positive TB patients on ART (antiretroviral therapy)
Oman
100.0%
in 2024
Sierra Leone
100.0%
in 2024
Oman rank
1st
Sierra Leone rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Oman
- Sierra Leone
How they compare
Oman currently reports 100.0% against 100.0% in Sierra Leone, a difference of 0.0%.
The two have swapped places 1 time across 16 shared years of data; in 2009 it was Oman ahead.
Oman ranks 1st and Sierra Leone ranks 1st of 144 countries.
Across the 3 decades both report, Oman averaged higher in 2 and Sierra Leone in 1.
Head to head by decade
| Decade | Oman | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 13.0% | 87.0% | Oman |
| 2010s | 93.1% | 69.6% | 23.5% | Oman |
| 2020s | 91.4% | 100.0% | 8.6% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Oman or Sierra Leone?
- Oman, at 100.0% against 100.0% in Sierra Leone as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Oman and Sierra Leone?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Sierra Leone?
- 16 years are reported by both, from 2009 to 2024.
- How do Oman and Sierra Leone rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Oman ranks 1st and Sierra Leone ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.